How to drive regulatory success with effective medical writing Submitting a dossier to the EMA or MHRA is [...]By TMC|2025-09-09T15:12:02+01:009 September 2025|Blog|0 Comments Read More
How to manage serious adverse events in early-phase clinical trials Reporting serious adverse events (SAE) is integral to running [...]By TMC|2025-09-08T10:09:56+01:008 September 2025|Blog|0 Comments Read More
Rare Conversations podcast: Will we ever have fully decentralised clinical trials in rare diseasesBy TMC|2025-08-08T13:17:57+01:008 August 2025|Podcast|0 Comments Read More
Rare Conversations podcast: The site perspectiveBy TMC|2025-08-08T13:16:18+01:008 August 2025|Podcast|0 Comments Read More
Rare Conversations podcast: Reducing the patient burdenBy TMC|2025-08-08T13:15:42+01:008 August 2025|Podcast|0 Comments Read More
Rare Conversations podcast: Patient enrolment & retentionBy TMC|2025-08-08T13:15:15+01:008 August 2025|Podcast|0 Comments Read More
Rare Conversations podcast: Planning & interrogating the protocolBy TMC|2025-08-08T13:14:38+01:008 August 2025|Podcast|0 Comments Read More
Rare Conversations podcast: Patient & regulatory acceptanceBy TMC|2025-08-08T13:14:05+01:008 August 2025|Podcast|0 Comments Read More
Rare Conversations podcast: Data collection & integrityBy TMC|2025-08-08T13:13:12+01:008 August 2025|Podcast|0 Comments Read More
Rare Conversations podcast: Regulatory fragmentation across countriesBy TMC|2025-08-08T13:13:31+01:008 August 2025|Podcast|0 Comments Read More